Income Statement (TTM)
Khiron Life Sciences Corp. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 8 | 9 | 10 | 12 | 13 | 15 | 16 | 16 |
| Change (%) | 0.09 | 11.67 | 12.65 | 15.78 | 9.57 | 14.12 | 11.44 | -0.83 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 5 | 1 | 1 | 1 | 2 | 6 | 8 | 9 | 9 |
| Change (%) | -78.00 | -18.71 | 38.57 | 62.12 | 248.63 | 29.16 | 13.76 | 0.29 | |
| % of Revenue | 57.27 | 12.59 | 9.16 | 11.27 | 15.78 | 50.21 | 56.82 | 58.01 | 58.66 |
| Gross Operating Profit | 3 | 7 | 8 | 9 | 10 | 6 | 6 | 7 | 7 |
| Change (%) | 104.76 | 16.04 | 10.04 | 9.90 | -35.22 | -1.04 | 8.37 | -2.37 | |
| % of Revenue | 42.73 | 87.41 | 90.84 | 88.73 | 84.22 | 49.79 | 43.18 | 41.99 | 41.34 |
| SG&A | 32 | 29 | 27 | 27 | 26 | 26 | 25 | 23 | 22 |
| Change (%) | -10.06 | -7.03 | -0.65 | -4.48 | 0.06 | -2.88 | -6.01 | -4.61 | |
| % of Revenue | 403.76 | 362.82 | 302.08 | 266.40 | 219.78 | 200.69 | 170.78 | 144.05 | 138.56 |
| R&D | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Change (%) | -31.26 | -39.09 | -0.70 | 14.54 | 15.02 | 16.53 | 36.70 | -9.60 | |
| % of Revenue | 27.72 | 19.03 | 10.38 | 9.15 | 9.05 | 9.50 | 9.70 | 11.90 | 10.85 |
| OpEx | 39 | 32 | 29 | 29 | 29 | 33 | 35 | 35 | 34 |
| Change (%) | -19.22 | -8.95 | 0.46 | -1.25 | 16.65 | 4.00 | 0.47 | -3.56 | |
| % of Revenue | 488.74 | 394.44 | 321.62 | 286.82 | 244.61 | 260.40 | 237.31 | 213.96 | 208.07 |
| Operating Income | -31 | -24 | -20 | -19 | -17 | -21 | -20 | -19 | -17 |
| Change (%) | -24.19 | -15.95 | -5.04 | -10.38 | 21.54 | -2.30 | -7.52 | -5.95 | |
| % of Revenue | -388.74 | -294.44 | -221.62 | -186.82 | -144.61 | -160.40 | -137.31 | -113.96 | -108.07 |
| Interest Expense | -0 | -0 | -1 | -1 | -0 | -0 | -0 | -0 | |
| Change (%) | 26.24 | 21.01 | -8.32 | -38.66 | 19.29 | -16.98 | 45.13 | ||
| % of Revenue | -4.52 | -5.10 | -5.48 | -4.34 | -2.43 | -2.54 | -1.89 | -2.77 | |
| Net Income | -30 | -24 | -20 | -19 | -16 | -33 | -33 | -30 | -31 |
| Change (%) | -19.60 | -15.57 | -4.52 | -17.43 | 107.04 | -0.25 | -7.94 | 0.79 | |
| % of Revenue | -373.31 | -299.85 | -226.71 | -192.16 | -137.03 | -258.92 | -226.32 | -186.96 | -190.00 |
Source: Capital IQ
